World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
81
Citations
28226
World Ranking
3827
National Ranking
247

Overview

Shigeru Chiba is affiliated with the University of Tsukuba in Japan and has an extensive publication record primarily in the field of Medicine with a focus on Hematology. Their research spans multiple specialized domains, including Genetics, Pathology and Forensic Medicine, Immunology, and Molecular Biology.

The scientist's work covers significant topics such as Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Hematopoietic Stem Cell Transplantation, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Immune Cell Function and Interaction, and Sleep and Wakefulness Research.

Key recent papers authored or co-authored by Shigeru Chiba include:

  • Advances in understanding of angioimmunoblastic T-cell lymphoma, 2020, Leukemia
  • Molecular International Prognostic Scoring System for Myelodysplastic Syndromes, 2022, NEJM Evidence
  • Chemically defined cytokine-free expansion of human haematopoietic stem cells, 2023, Nature
  • Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial, 2022, Blood
  • Germ line DDX41 mutations define a unique subtype of myeloid neoplasms, 2022, Blood

Shigeru Chiba frequently publishes in these venues:

  • Blood
  • PubMed
  • Leukemia
  • Cancer Science
  • International Journal of Hematology

Frequent co-authors include:

  • Mamiko Sakata-Yanagimoto
  • Tatsuhiro Sakamoto
  • Hidekazu Nishikii
  • Yasuhito Suehara
  • Naoshi Obara

Best Publications

  • Frequent pathway mutations of splicing machinery in myelodysplasia

    Kenichi Yoshida;Masashi Sanada;Yuichi Shiraishi;Daniel Nowak

  • Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin

    Toshio Kitamura;Tsuyoshi Tange;Takashi Terasawa;Shigeru Chiba

  • AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.

    Motoshi Ichikawa;Takashi Asai;Toshiki Saito;Go Yamamoto

  • Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development.

    Toshiki Saito;Shigeru Chiba;Motoshi Ichikawa;Atsushi Kunisato

  • Somatic RHOA mutation in angioimmunoblastic T cell lymphoma

    Mamiko Sakata-Yanagimoto;Terukazu Enami;Kenichi Yoshida;Yuichi Shiraishi

  • Frequent inactivation of A20 in B-cell lymphomas

    Motohiro Kato;Masashi Sanada;Itaru Kato;Yasuharu Sato

  • Notch1 but Not Notch2 Is Essential for Generating Hematopoietic Stem Cells from Endothelial Cells

    Keiki Kumano;Shigeru Chiba;Atsushi Kunisato;Masataka Sata

  • Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    Elsa Bernard;Yasuhito Nannya;Robert P. Hasserjian;Sean M. Devlin

  • Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.

    Masashi Sanada;Takahiro Suzuki;Lee-Yung Shih;Makoto Otsu

  • F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation.

    Qi Dong Hu;Qi Dong Hu;Beng Ti Ang;Beng Ti Ang;Meliha Karsak;Wei Ping Hu

  • The oncoprotein Evi-1 represses TGF-Beta signalling by inhibiting Smad3

    Mineo Kurokawa;Kinuko Mitani;Kenji Irie;Tomohiro Matsuyama

  • Dynamics of clonal evolution in myelodysplastic syndromes

    Hideki Makishima;Hideki Makishima;Tetsuichi Yoshizato;Kenichi Yoshida;Mikkael Sekeres

  • Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms

    Ayana Kon;Lee Yung Shih;Masashi Minamino;Masashi Sanada;Masashi Sanada

  • Delta1-Notch3 Interactions Bias the Functional Differentiation of Activated CD4+ T Cells

    Yoichi Maekawa;Shin-ichi Tsukumo;Shigeru Chiba;Hisamaru Hirai

  • Prospective Comparison of the Diagnostic Potential of Real-Time PCR, Double-Sandwich Enzyme-Linked Immunosorbent Assay for Galactomannan, and a (1→3)-β-d-Glucan Test in Weekly Screening for Invasive Aspergillosis in Patients with Hematological Disorders

    Masahito Kawazu;Yoshinobu Kanda;Yasuhito Nannya;Katsunori Aoki

  • Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells.

    Susumu Goyama;Go Yamamoto;Munetake Shimabe;Tomohiko Sato

  • Highly Sensitive Method for Genomewide Detection of Allelic Composition in Nonpaired, Primary Tumor Specimens by Use of Affymetrix Single-Nucleotide–Polymorphism Genotyping Microarrays

    Go Yamamoto;Yasuhito Nannya;Motohiro Kato;Masashi Sanada

  • Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells.

    Tsuyoshi Takahashi;Shigeru Chiba;Mie Nieda;Takeshi Azuma

  • Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity

    Yoichi Maekawa;Yoshiaki Minato;Chieko Ishifune;Takeshi Kurihara

  • Frequent Pathway Mutations of Splicing Machinery in Myelodysplasia

    Kenichi Yoshida;Masashi Sanada;Yuichi Shiraishi;Daniel Nowak

Frequent Co-Authors

Seishi Ogawa
Seishi Ogawa Kyoto University
Mineo Kurokawa
Mineo Kurokawa University of Tokyo
Hisamaru Hirai
Hisamaru Hirai University of Tokyo
Masashi Sanada
Masashi Sanada Kyoto University
Yuichi Shiraishi
Yuichi Shiraishi University of Tokyo
Satoru Miyano
Satoru Miyano Tokyo Medical and Dental University
Yoshio Yazaki
Yoshio Yazaki University of Tokyo
kenichi yoshida
kenichi yoshida Kyoto University
Yusuke Shiozawa
Yusuke Shiozawa Wake Forest University
H. Phillip Koeffler
H. Phillip Koeffler Cedars-Sinai Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Shigeru Chiba

Trending Scientists

Recently Published Articles